183 related articles for article (PubMed ID: 2038641)
1. [Principles of hormone substitution in the postmenopause period].
Keller PJ
Schweiz Rundsch Med Prax; 1991 Apr; 80(16):431-4. PubMed ID: 2038641
[TBL] [Abstract][Full Text] [Related]
2. [Hormone substitution in the female climacteric--goals, means, effects].
Hauser GA
Ther Umsch; 1990 Dec; 47(12):970-84. PubMed ID: 2096481
[TBL] [Abstract][Full Text] [Related]
3. [Hormone substitution in menopause].
Keller PJ; Maurer-Major E
Praxis (Bern 1994); 1997 Sep; 86(38):1458-62. PubMed ID: 9381046
[TBL] [Abstract][Full Text] [Related]
4. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
5. [Postmenopausal estrogen therapy: pharmacological treatment or replacement of the lacking hormone?].
Lippert TH; Seeger H; Mueck AO
Dtsch Med Wochenschr; 1999 Oct; 124(42):1245-8. PubMed ID: 10572534
[No Abstract] [Full Text] [Related]
6. HRT dosing regimens: continuous versus cyclic-pros and cons.
Shoupe D
Int J Fertil Womens Med; 2001; 46(1):7-15. PubMed ID: 11294619
[TBL] [Abstract][Full Text] [Related]
7. [Estrogen substitution in the postmenopause--effect and compliance].
Dören M
Ther Umsch; 1994 Nov; 51(11):767-72. PubMed ID: 7839335
[TBL] [Abstract][Full Text] [Related]
8. A practical guide to prescribing estrogen replacement therapy.
Corson SL
Int J Fertil Menopausal Stud; 1995; 40(5):229-47. PubMed ID: 8556028
[TBL] [Abstract][Full Text] [Related]
9. The rationale for a wider range of progestogens.
Skouby SO
Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382
[TBL] [Abstract][Full Text] [Related]
10. [Estrogen replacement therapy: for whom, why and how?].
Rozenberg S; Neusy S; Barudy J; Fellemans C; Jahjah L
Rev Med Brux; 2002 Sep; 23(4):A382-9. PubMed ID: 12422465
[TBL] [Abstract][Full Text] [Related]
11. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated].
Emons G; Westphalen S
MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648
[TBL] [Abstract][Full Text] [Related]
12. Update on continuous estrogen-progestin replacement therapy.
Rosenfeld JA
Am Fam Physician; 1994 Nov; 50(7):1519-23, 1527-8. PubMed ID: 7976988
[TBL] [Abstract][Full Text] [Related]
13. [Hormone replacement therapy and cardiovascular risk].
Maffei S; De Caterina R
G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
[TBL] [Abstract][Full Text] [Related]
14. Postmenopausal hormone replacement therapy: does the progestin make a difference?
Fylstra DL
J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
[No Abstract] [Full Text] [Related]
15. Hormone replacement therapy in postmenopausal women.
Yasui T; Uemura H; Takikawa M; Irahara M
J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
[TBL] [Abstract][Full Text] [Related]
16. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
van de Weijer PH; Mattsson LA; Ylikorkala O
Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and progestin supplementation.
Nurse Pract; 1995 Mar; 20(3):63-6. PubMed ID: 7761042
[No Abstract] [Full Text] [Related]
18. Prognostic features of menopausal and postmenopausal applicants for life insurance.
Schiefeling M
J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
[TBL] [Abstract][Full Text] [Related]
19. [Effects of estrogens and progestogens on the lipid profile in postmenopausal hypogonadism].
García L; Hernández I; Cervera Aguilar R; Ayala AR
Ginecol Obstet Mex; 2001 Sep; 69():351-4. PubMed ID: 11816532
[TBL] [Abstract][Full Text] [Related]
20. [Secondary prevention in coronary diseases. Viewpoint of the gynecological endocrinologist].
Hänggi W
Praxis (Bern 1994); 1997 Jan; 86(5):145-9. PubMed ID: 9064732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
